About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Fatigue Reduction in Chronic Kidney Disease (CKD)

NCT06768983·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

NYU Langone Health

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Interest in participating in a fatigue study
Age ≥18 years old
Estimated glomerular filtration rate (eGFR) 15-44 mL/min/1.73 m2
Ability and willingness to provide informed consent
Ability to speak English
Ability to walk
Ability to join remote study sessions via WebEx

You may not be if

Current involvement in an activity/exercise program
High likelihood of a kidney transplant within 6 months (assessed via the medical record)
Any safety concerns about increased walking (assessed via the medical record)

The record

StatusCompleted

PhaseNo phase

Taking part5

StartedJan 2025

UpdatedDec 18, 2025

Conditions

Chronic Kidney Diseases Fatigue

Where1

NYU Langone Health
New York, New York, United States

Clareo Health | Fatigue Reduction in Chronic Kidney Disease (CKD)